Atezolizumab Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Cancer and Advancements in Immunotherapy

The Atezolizumab Market is estimated to be valued at US$ 2.68 billion in 2023 and is expected to exhibit a CAGR of 16.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:The Atezolizumab Market refers to the market for Atezolizumab, a monoclonal antibody used … Read more